Curium Pharma has raised not fully disclosed across 1 funding round. The latest round valued Curium Pharma at $7B post-money, with ICG, TPG GP Solutions, CVC Secondary Partners on the lead line.
1 funding round, the latest highlighted.
Curium Pharma was founded in 2000, France.
Goldman Sachs Alternatives, Lunate, Pantheon, Ardian, TPG Life Sciences Innovations. Led by ICG, TPG GP Solutions, CVC Secondary Partners.
No filing has been made.
1 dated round, newest first.
TPGCCVC Capital PartnersGGoldman Sachs Alternatives
LunatePPantheonAArdianThe last valuation is $7B.
Lead investors for each round are in the funding timeline.
The routes section explains what is realistically available for a company at this stage.
No. Curium Pharma is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
